mTOR是衰老和与年龄有关的疾病的关键调节器
Simon C Johnson1, Peter S Rabinovitch, Matt Kaeberlein
1Department of Pathology, University of Washington, Seattle, Washington 98195, USA.
Nature
|January 18, 2013
概括
针对拉巴胺素 (mTOR) 途径的机械性标的药理干预措施显示出减缓衰老的前景. 虽然目前的药物有副作用,但未来的疗法可以减少与年龄相关的疾病.
科学领域:
- 老年病学和药理学.
- 细胞信号传递途径 细胞信号传递途径
- 开发药物治疗衰老的方法
背景情况:
- 衰老是一个复杂的生物过程,对干预措施的研究越来越多.
- 拉巴胺素 (mTOR) 途径的机械性标是细胞对营养素反应的关键调节者.
- 在模型生物中,mTOR通路的抑制已经证明了寿命延长和对与年龄相关的疾病的保护.
研究的目的:
- 审查针对mTOR途径的药理干预措施减缓衰老的潜力.
- 讨论mTOR抑制剂在人类健康中的现状和未来前景.
主要方法:
- 对mTOR途径和衰老研究的文献综述.
- 对mTOR抑制剂现有临床数据的分析.
- 讨论潜在的治疗应用和挑战.
主要成果:
- 抑制mTOR途径可以延长各种模型生物的寿命和改善健康寿命.
- 几种mTOR抑制剂已经被批准用于临床使用,其他正在开发中.
- 目前,副作用限制了mTOR抑制剂在健康人群中的使用.
结论:
- 对mTOR途径的药理向是一种减缓人类衰老的有希望的策略.
- 需要进一步的研究和开发来克服副作用并优化治疗用途.
- mTOR 抑制剂在治疗与年龄相关的疾病和促进长寿方面可能变得至关重要.
相关概念视频
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
Mitochondria
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
The Effect of Aging on Tissues
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...

